Ironwood Pharmaceuticals (IRWD) Short-term Investments (2010 - 2023)

Ironwood Pharmaceuticals has disclosed Short-term Investments across 14 years of filings, most recently posting $788000.0 for Q3 2023.

• Short-term Investments for Q3 2023 came in at $788000.0, down 36.96% year-over-year; the trailing twelve-month figure through Sep 2023 was $788000.0 (down 36.96% YoY), and the FY2022 annual result was $1.3 million, changed 0.0% from the prior year.
• Short-term Investments came in at $788000.0 for Q3 2023 at Ironwood Pharmaceuticals, roughly flat from $788000.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $7.7 million in Q2 2019 to a low of $788000.0 in Q2 2023.
• The 5-year median for Short-term Investments is $1.2 million (2019), against an average of $2.0 million.
• Across the five-year window, Short-term Investments slumped 97.48% in 2019 and jumped 38.8% in 2021, its largest moves.
• Ironwood Pharmaceuticals' Short-term Investments stood at $1.2 million in 2019, then surged by 36.0% to $1.7 million in 2020, then fell by 23.53% to $1.3 million in 2021, then changed by 0.0% to $1.3 million in 2022, then plunged by 39.38% to $788000.0 in 2023.
• The last three Short-term Investments figures came in at $788000.0 (Q3 2023), $788000.0 (Q2 2023), and $1.2 million (Q1 2023), per Business Quant data.